Publication:
Middle-term outcomes in renal transplant recipients with covid-19: A national, multicenter, controlled study

Simple item page
dc.contributor.authorVELİOĞLU, ARZU
dc.contributor.authorKAYA, BURCU
dc.contributor.authorsOto O. A., Ozturk S., ARICI M., VELİOĞLU A., DURSUN B., Guller N., ŞAHİN İ., Eser Z. E., PAYDAŞ S., TRABULUS S., et al.
dc.date.accessioned2023-04-03T10:26:41Z
dc.date.available2023-04-03T10:26:41Z
dc.date.issued2022-04-01
dc.description.abstractBackground In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization for any reason, lower respiratory tract infection, urinary tract infection, biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease and BK viruria/viremia at 3 months. Results A total of 944 KTR from 29 different centers were included in this study (523 patients in the COVID-19 group; 421 patients in the control group). The mean age was 46 +/- 12 years (interquartile range 37-55) and 532 (56.4%) of them were male. Total number of deaths was 8 [7 (1.3%) in COVID-19 group, 1 (0.2%) in control group; P = 0.082]. The proportion of patients with ongoing respiratory symptoms [43 (8.2%) versus 4 (1.0%); P Conclusion The prevalence of ongoing respiratory symptoms increased in the first 3 months post-COVID in KTRs who have recovered from COVID-19, but mortality was not significantly different.
dc.identifier.citationOto O. A., Ozturk S., ARICI M., VELİOĞLU A., DURSUN B., Guller N., ŞAHİN İ., Eser Z. E., PAYDAŞ S., TRABULUS S., et al., "Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study", CLINICAL KIDNEY JOURNAL, cilt.15, sa.5, ss.999-1006, 2022
dc.identifier.doi10.1093/ckj/sfac045
dc.identifier.endpage1006
dc.identifier.issn2048-8505
dc.identifier.issue5
dc.identifier.startpage999
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/35498893/
dc.identifier.urihttps://hdl.handle.net/11424/288092
dc.identifier.volume15
dc.language.isoeng
dc.relation.ispartofCLINICAL KIDNEY JOURNAL
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectNephrology
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectUROLOGY & NEPHROLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectUrology
dc.subjectCOVID-19
dc.subjectkidney transplantation
dc.subjectmortality
dc.subjectoutcome
dc.subjectregistry
dc.subjectCOVID-19
dc.subjectkidney transplantation
dc.subjectmortality
dc.subjectoutcome
dc.subjectregistry
dc.titleMiddle-term outcomes in renal transplant recipients with covid-19: A national, multicenter, controlled study
dc.typearticle
dspace.entity.typePublication
local.avesis.idc6670a67-228b-432f-9f0d-d3d9b99d249c
local.indexed.atWOS
local.indexed.atPUBMED
local.indexed.atSCOPUS
relation.isAuthorOfPublicationa7410f0e-0eb4-4b83-ad61-a71dfbee164f
relation.isAuthorOfPublicationda10fad1-7b06-4e4b-866c-ad9a39663ce1
relation.isAuthorOfPublication.latestForDiscoverya7410f0e-0eb4-4b83-ad61-a71dfbee164f

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
4.pdf
Size:
1.76 MB
Format:
Adobe Portable Document Format
Download

Collections

Research Outputs